AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative

Importance. The anticoagulant warfarin has been shown to interact with other medications, vitamin K containing foods, and over-the-counter products. These interactions may inhibit or potentiate the effect of warfarin, resulting in serious clotting or bleeding events. Observations. We report the cas...

Full description

Saved in:
Bibliographic Details
Main Authors: Eric Puroll, Steven T. Heidt, Brian Haymart, James B. Froehlich, Eva Kline-Rogers, Geoffrey D. Barnes
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2014/754147
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850170486272557056
author Eric Puroll
Steven T. Heidt
Brian Haymart
James B. Froehlich
Eva Kline-Rogers
Geoffrey D. Barnes
author_facet Eric Puroll
Steven T. Heidt
Brian Haymart
James B. Froehlich
Eva Kline-Rogers
Geoffrey D. Barnes
author_sort Eric Puroll
collection DOAJ
description Importance. The anticoagulant warfarin has been shown to interact with other medications, vitamin K containing foods, and over-the-counter products. These interactions may inhibit or potentiate the effect of warfarin, resulting in serious clotting or bleeding events. Observations. We report the case of an 84-year-old woman with atrial fibrillation, prescribed warfarin in May 2010 for stroke prevention. Her international normalized ratio (INR) was stable until April 2013, when she was prescribed AREDS (Age Related Eye Disease Study) formula pills, an eye vitamin compound, to slow the progression of age-related macular degeneration. This change was not reported to the Anticoagulation Service. Eighteen days later, she presented to the ED with groin and back pain and an INR of 10.4. An abdominal CT revealed a retroperitoneal hemorrhage with extension in multiple muscles. Both warfarin and AREDS were discontinued and the patient was discharged to subacute rehabilitation. This case was reviewed by the Anticoagulation Service and actions were taken to prevent similar adverse events. Conclusions. This report provides an example of the potential danger of supplement use, in this case, AREDS formula, in patients prescribed warfarin, and the importance of communicating medication changes to the providers responsible for warfarin management.
format Article
id doaj-art-9dc48ba5b0fc4b71a6e298e21a9ca4d4
institution OA Journals
issn 1687-9627
1687-9635
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-9dc48ba5b0fc4b71a6e298e21a9ca4d42025-08-20T02:20:29ZengWileyCase Reports in Medicine1687-96271687-96352014-01-01201410.1155/2014/754147754147AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement InitiativeEric Puroll0Steven T. Heidt1Brian Haymart2James B. Froehlich3Eva Kline-Rogers4Geoffrey D. Barnes5University of Michigan Health System, Domino’s Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USAUniversity of Michigan Health System, Domino’s Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USAUniversity of Michigan Health System, Domino’s Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USAUniversity of Michigan Health System, Domino’s Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USAUniversity of Michigan Health System, Domino’s Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USAUniversity of Michigan Health System, Domino’s Farms, Lobby A, MCORRP, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, USAImportance. The anticoagulant warfarin has been shown to interact with other medications, vitamin K containing foods, and over-the-counter products. These interactions may inhibit or potentiate the effect of warfarin, resulting in serious clotting or bleeding events. Observations. We report the case of an 84-year-old woman with atrial fibrillation, prescribed warfarin in May 2010 for stroke prevention. Her international normalized ratio (INR) was stable until April 2013, when she was prescribed AREDS (Age Related Eye Disease Study) formula pills, an eye vitamin compound, to slow the progression of age-related macular degeneration. This change was not reported to the Anticoagulation Service. Eighteen days later, she presented to the ED with groin and back pain and an INR of 10.4. An abdominal CT revealed a retroperitoneal hemorrhage with extension in multiple muscles. Both warfarin and AREDS were discontinued and the patient was discharged to subacute rehabilitation. This case was reviewed by the Anticoagulation Service and actions were taken to prevent similar adverse events. Conclusions. This report provides an example of the potential danger of supplement use, in this case, AREDS formula, in patients prescribed warfarin, and the importance of communicating medication changes to the providers responsible for warfarin management.http://dx.doi.org/10.1155/2014/754147
spellingShingle Eric Puroll
Steven T. Heidt
Brian Haymart
James B. Froehlich
Eva Kline-Rogers
Geoffrey D. Barnes
AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
Case Reports in Medicine
title AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
title_full AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
title_fullStr AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
title_full_unstemmed AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
title_short AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
title_sort areds formula warfarin and bleeding a case report from the michigan anticoagulation quality improvement initiative
url http://dx.doi.org/10.1155/2014/754147
work_keys_str_mv AT ericpuroll aredsformulawarfarinandbleedingacasereportfromthemichigananticoagulationqualityimprovementinitiative
AT steventheidt aredsformulawarfarinandbleedingacasereportfromthemichigananticoagulationqualityimprovementinitiative
AT brianhaymart aredsformulawarfarinandbleedingacasereportfromthemichigananticoagulationqualityimprovementinitiative
AT jamesbfroehlich aredsformulawarfarinandbleedingacasereportfromthemichigananticoagulationqualityimprovementinitiative
AT evaklinerogers aredsformulawarfarinandbleedingacasereportfromthemichigananticoagulationqualityimprovementinitiative
AT geoffreydbarnes aredsformulawarfarinandbleedingacasereportfromthemichigananticoagulationqualityimprovementinitiative